Schneyer Mark C. 4
4 · ACADIA PHARMACEUTICALS INC · Filed May 19, 2025
Insider Transaction Report
Form 4
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-05-16$25.00/sh−2,000$50,000→ 62,130 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.
- [F2]Includes 1,357 shares of the Issuer's common stock acquired by the Reporting Person on May 15, 2025 pursuant to an employee stock purchase plan.